BALVERSA is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Janssen Products Lp. The primary component is Erdafitinib.
Product ID | 59676-030_11688298-6399-11ea-8a95-3feefb2ca371 |
NDC | 59676-030 |
Product Type | Human Prescription Drug |
Proprietary Name | BALVERSA |
Generic Name | Erdafitinib |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2019-04-12 |
Marketing Category | NDA / NDA |
Application Number | NDA212018 |
Labeler Name | Janssen Products LP |
Substance Name | ERDAFITINIB |
Active Ingredient Strength | 3 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2019-04-12 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA212018 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-04-12 |
Marketing Category | NDA |
Application Number | NDA212018 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-04-12 |
Ingredient | Strength |
---|---|
ERDAFITINIB | 3 mg/1 |
SPL SET ID: | 2a8aa5c0-6c92-4566-8c45-e8f4d1fc20ee |
Manufacturer | |
UNII |
NDC | Brand Name | Generic Name |
---|---|---|
59676-030 | BALVERSA | Erdafitinib |
59676-040 | BALVERSA | Erdafitinib |
59676-050 | BALVERSA | Erdafitinib |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
BALVERSA 87362785 5794954 Live/Registered |
Johnson & Johnson 2017-03-08 |